BMI independently relates to glycaemia in patients with severe enduring mental illness (SMI)

References

• American Diabetes Association. (2004). ADA consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596–601
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet P, Shaw J. (2006). Metabolic syndrome – a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med, 23, 469–80
   PubMed Web of Science ®Google Scholar
• Allison DB, Fontaine KR, Moonseong H, et al. (1999). The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry, 60, 215–20
   PubMed Web of Science ®Google Scholar
• Banerji MA, Lebowitz J, Chaiken RL, et al. (2007). Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol, 273, e425–32
   Google Scholar
• Barnett AH, Mackin P, Chaudhry I, et al. (2007). Minimising metabolic and cardiovascular risk in schizophrenia: Diabetes, obesity and dyslipidaemia. J Psychopharmacol, 21, 357–73
   PubMed Web of Science ®Google Scholar
• Brown S. (1997). Excess mortality of schizophrenia: A meta-analysis. Br J Psychiatry, 171, 502–8
   PubMed Web of Science ®Google Scholar
• De Hert M, van Winkel R, van Eyck D, et al. (2006). Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: A cross-sectional study. Clin Pract Epidemiol Ment Health, 2, 14
   PubMedGoogle Scholar
• De Hert M, Dekker JM, Wood D, et al. (2009). Cardiovascular disease and diabetes in people with severe mental illness. Position statement from the European psychiatric association (EPA), supported by the European association for the study of diabetes (EASD) and the European society of cardiology (ESC). Eur Psychiatry, 24, 412–42
   PubMed Web of Science ®Google Scholar
• De Hert M, Correll CU, Bobes J, et al. (2011). Physical illness in patients with severe mental disorders. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10, 52–77
   PubMed Web of Science ®Google Scholar
• Field AE, Coakley EH, Must A, et al. (2001). Impact of overweight of the risk of developing common chronic diseases during a 10-year period. Arch Intern Med, 161, 1581–86
   PubMed Web of Science ®Google Scholar
• Glynn LG, Murphy AW, Smith SM, et al. (2010). Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: A systematic review. Br J Gen Pract, 60, e476–88
   PubMed Web of Science ®Google Scholar
• Hardy, S. (2009). Maintaining physical health in severe mental illness. Independent Nurse, 2, 26–27
   Google Scholar
• Hardy S, Hinks P, Gray R. (2013). Screening for cardiovascular risk in patients with severe mental illness in primary care: A comparison with patients with diabetes. J Ment Health, 22, 42–50
   PubMed Web of Science ®Google Scholar
• Hardy S, Hinks P, Gray R. (2014). Does training practice nurses to carry out physical health checks for people with severe mental illness increase the level of screening for cardiovascular risk? Int J Soc Psychiatry, 60, 236–42
   PubMed Web of Science ®Google Scholar
• Heald AH, Cruickshank JK, Riste LK, et al. (2001). Close relationship of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in 2 populations. Diabetologia, 44, 333–39
   PubMed Web of Science ®Google Scholar
• Holt RI, Bushe C, Citrome L (2005). Diabetes and schizophrenia: Are we any closer to understanding the link? J Psychopharmacol, 19, 56–65. Available from: https://www.england.nhs.uk/wp-content/uploads/2015/03/9-cquin-guid-2015-16.pdf [last accessed 8 Mar 2016]
   PubMedGoogle Scholar
• Langan-Martin J, Lowrie R, McConnachie A, et al. (2014). Physical health indicators in major mental illness: Evidence of reduced uptake from UK-Wide QOF data. Br J Gen Pract, 64, e649–56
   PubMed Web of Science ®Google Scholar
• Marder SR, Essock SM, Miller AL, et al. (2004). Physical health monitoring of patients with schizophrenia. Am J Psychiatry, 161, 1334–49
   PubMed Web of Science ®Google Scholar
• Mitchell A, Hardy S. (2013). Surveillance for metabolic risk factors in patients with severe mental illness vs. diabetes: National comparison of screening practices. Psychiatr Serv, 64, 1060–3
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). (2014). Psychosis and schizophrenia in adults: treatment and management [CG178]. London: National Institute for Health and Care Excellence
   Google Scholar
• Newcomer JW. (2005). Second-generation (atypical) antipsychotics and metabolic effects. CNS Drugs, 19, 1–93
   PubMed Web of Science ®Google Scholar
• Osborne DP, Levy G, Nazareth I, et al. (2007). Relative risk of cardiovascular and cancer mortality in people with severe enduring mental illness from the United Kingdom’s general practice research database. Arch Gen Psychiatry, 64, 242–49
   PubMed Web of Science ®Google Scholar
• Reilly S, Olier I, Planner C, et al. (2015). Inequalities in physical comorbidity: A longitudinal comparative cohort study of people with severe mental illness in the UK. BMJ Open, 5, e009010
   PubMed Web of Science ®Google Scholar